139 results
8-K
EX-2.1
VYNT
Vyant Bio, Inc.
3 Nov 22
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
9:10am
6.03
Indemnification for Taxes
Section 6.04
Post-Closing Access and Cooperation
Section 6.05
Survival
Article VII Indemnification
Section 7.01
Survival … by Purchaser, Purchaser shall cause the Company to provide Seller and its Representatives with reasonable access, during normal business hours
8-K
EX-99.1
oagetqd
16 May 22
Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights
8:30am
424B4
2vq 4vjly1a7g6
12 May 22
Prospectus supplement with pricing info
9:12am
8-K
EX-1.1
vm5wyukh4x
8 Apr 22
Entry into a Material Definitive Agreement
7:00pm
424B5
5nmw9 x5ncg
8 Apr 22
Prospectus supplement for primary offering
6:15pm
POS AM
tv0lirg4sty3ibcdd9hl
18 May 21
Prospectus update (post-effective amendment)
12:00am
8-K
EX-99.1
k1cdq8gugnuw
17 May 21
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
5:27pm